CSS LLC’s Takeda Pharmaceutical TAK Stock Holding History

CSS LLC’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-54,384	Closed	-$978K	–	1049
2020 Q4	$990K	Buy	54,384 +7,500	+16%	+$132K	0.04%	320
2020 Q3	$836K	Buy	46,884 +3,651	+8%	+$66.5K	0.04%	326
2020 Q2	$775K	Sell	43,233 -12,802	-23%	-$230K	0.04%	313
2020 Q1	$851K	Sell	56,035 -64,326	-53%	-$1.17M	0.07%	227
2019 Q4	$2.38M	Sell	120,361 -21,392	-15%	-$409K	0.13%	139
2019 Q3	$2.44M	Buy	141,753 +8,826	+7%	+$153K	0.16%	116
2019 Q2	$2.35M	Buy	132,927 +3,591	+3%	+$65.3K	0.14%	131
2019 Q1	$2.63M	Buy	+129,336	New	+$2.6M	0.16%	109

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CSS LLC's TAK Position: Q1 2021 in Review

CSS LLC sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 54,384 shares — an estimated $978K sold.

CSS LLC first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $2.63M in Q1 2019. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

CSS LLC reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
CSS LLC sold 54,384 Takeda Pharmaceutical shares in Q1 2021, an estimated $978K.
CSS LLC first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
CSS LLC's Takeda Pharmaceutical position peaked at $2.63M in Q1 2019.
316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.